HER2-Positive Gastric or Gastroesophageal Junction Cancer

People with gastroesophageal junction cancer are asked to participate in a research study being conducted by Queens Hospital Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have histologically confirmed diagnosis of untreated locally advanced unresectable or metastatic HER2+ GC
  • Have adequate organ function

You may NOT participate in this study if you:

  • Have received investigational treatment in another clinical study within the past 4 weeks
  • Have had major surgery within 4 weeks prior to start of study treatment
  • Have any serious underlying medical or psychiatric condition
  • Have known immunodeficiency virus (HIV) infection, hepatitis B, hepatitis C, or hepatitis D with B
  • Are pregnant or breastfeeding

Contact Information
Linda Bulone, RN Study Coordinator
82-68 164th St.
Jamaica, NY 11432
Phone: (718) 883-3751
Email: bulonel@NYCHHC.org